The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anticoagulant-Global Market Insights and Sales Trends 2024
Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulant market size is expected to reach US$ 36030 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoagulant in various end use industries. The expanding demands from the DVT, PE and AF,, are propelling Anticoagulant market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoagulant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoagulant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoagulant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoagulant sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoagulant covered in this report include Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Johnson & Johnson, Sanofi, AstraZeneca and Eli Lilly, etc.
The global Anticoagulant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Global Anticoagulant market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoagulant market, Segment by Type:
Oral
Injectable
Global Anticoagulant market, by Application
DVT
PE
AF
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anticoagulant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anticoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulant market size is expected to reach US$ 36030 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoagulant in various end use industries. The expanding demands from the DVT, PE and AF,, are propelling Anticoagulant market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoagulant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoagulant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoagulant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoagulant sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoagulant covered in this report include Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Johnson & Johnson, Sanofi, AstraZeneca and Eli Lilly, etc.
The global Anticoagulant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Global Anticoagulant market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoagulant market, Segment by Type:
Oral
Injectable
Global Anticoagulant market, by Application
DVT
PE
AF
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anticoagulant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anticoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Anticoagulant Market Overview
1.1 Anticoagulant Product Overview
1.2 Anticoagulant Market Segment by Type
1.2.1 Oral
1.2.2 Injectable
1.3 Global Anticoagulant Market Size by Type
1.3.1 Global Anticoagulant Market Size Overview by Type (2018-2029)
1.3.2 Global Anticoagulant Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anticoagulant Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anticoagulant Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anticoagulant Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anticoagulant Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anticoagulant Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anticoagulant Sales Breakdown by Type (2018-2023)
2 Global Anticoagulant Market Competition by Company
2.1 Global Top Players by Anticoagulant Sales (2018-2023)
2.2 Global Top Players by Anticoagulant Revenue (2018-2023)
2.3 Global Top Players by Anticoagulant Price (2018-2023)
2.4 Global Top Manufacturers Anticoagulant Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anticoagulant Market Competitive Situation and Trends
2.5.1 Anticoagulant Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anticoagulant Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant as of 2022)
2.7 Date of Key Manufacturers Enter into Anticoagulant Market
2.8 Key Manufacturers Anticoagulant Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anticoagulant Status and Outlook by Region
3.1 Global Anticoagulant Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anticoagulant Historic Market Size by Region
3.2.1 Global Anticoagulant Sales in Volume by Region (2018-2023)
3.2.2 Global Anticoagulant Sales in Value by Region (2018-2023)
3.2.3 Global Anticoagulant Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anticoagulant Forecasted Market Size by Region
3.3.1 Global Anticoagulant Sales in Volume by Region (2024-2029)
3.3.2 Global Anticoagulant Sales in Value by Region (2024-2029)
3.3.3 Global Anticoagulant Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anticoagulant by Application
4.1 Anticoagulant Market Segment by Application
4.1.1 DVT
4.1.2 PE
4.1.3 AF
4.2 Global Anticoagulant Market Size by Application
4.2.1 Global Anticoagulant Market Size Overview by Application (2018-2029)
4.2.2 Global Anticoagulant Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anticoagulant Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anticoagulant Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anticoagulant Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anticoagulant Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anticoagulant Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anticoagulant Sales Breakdown by Application (2018-2023)
5 North America Anticoagulant by Country
5.1 North America Anticoagulant Historic Market Size by Country
5.1.1 North America Anticoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anticoagulant Sales in Volume by Country (2018-2023)
5.1.3 North America Anticoagulant Sales in Value by Country (2018-2023)
5.2 North America Anticoagulant Forecasted Market Size by Country
5.2.1 North America Anticoagulant Sales in Volume by Country (2024-2029)
5.2.2 North America Anticoagulant Sales in Value by Country (2024-2029)
6 Europe Anticoagulant by Country
6.1 Europe Anticoagulant Historic Market Size by Country
6.1.1 Europe Anticoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anticoagulant Sales in Volume by Country (2018-2023)
6.1.3 Europe Anticoagulant Sales in Value by Country (2018-2023)
6.2 Europe Anticoagulant Forecasted Market Size by Country
6.2.1 Europe Anticoagulant Sales in Volume by Country (2024-2029)
6.2.2 Europe Anticoagulant Sales in Value by Country (2024-2029)
7 Asia-Pacific Anticoagulant by Region
7.1 Asia-Pacific Anticoagulant Historic Market Size by Region
7.1.1 Asia-Pacific Anticoagulant Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anticoagulant Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anticoagulant Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anticoagulant Forecasted Market Size by Region
7.2.1 Asia-Pacific Anticoagulant Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anticoagulant Sales in Value by Region (2024-2029)
8 Latin America Anticoagulant by Country
8.1 Latin America Anticoagulant Historic Market Size by Country
8.1.1 Latin America Anticoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anticoagulant Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anticoagulant Sales in Value by Country (2018-2023)
8.2 Latin America Anticoagulant Forecasted Market Size by Country
8.2.1 Latin America Anticoagulant Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anticoagulant Sales in Value by Country (2024-2029)
9 Middle East and Africa Anticoagulant by Country
9.1 Middle East and Africa Anticoagulant Historic Market Size by Country
9.1.1 Middle East and Africa Anticoagulant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anticoagulant Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anticoagulant Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anticoagulant Forecasted Market Size by Country
9.2.1 Middle East and Africa Anticoagulant Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anticoagulant Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Anticoagulant Products Offered
10.1.5 Bayer Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Anticoagulant Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Information
10.3.2 Bristol-Myers Squibb Introduction and Business Overview
10.3.3 Bristol-Myers Squibb Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bristol-Myers Squibb Anticoagulant Products Offered
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Daiichi Sankyo
10.4.1 Daiichi Sankyo Company Information
10.4.2 Daiichi Sankyo Introduction and Business Overview
10.4.3 Daiichi Sankyo Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Daiichi Sankyo Anticoagulant Products Offered
10.4.5 Daiichi Sankyo Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Anticoagulant Products Offered
10.5.5 Pfizer Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Anticoagulant Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanofi Anticoagulant Products Offered
10.7.5 Sanofi Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Introduction and Business Overview
10.8.3 AstraZeneca Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AstraZeneca Anticoagulant Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eli Lilly Anticoagulant Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Keryx Biopharmaceuticals
10.10.1 Keryx Biopharmaceuticals Company Information
10.10.2 Keryx Biopharmaceuticals Introduction and Business Overview
10.10.3 Keryx Biopharmaceuticals Anticoagulant Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Keryx Biopharmaceuticals Anticoagulant Products Offered
10.10.5 Keryx Biopharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anticoagulant Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anticoagulant Industrial Chain Analysis
11.4 Anticoagulant Market Dynamics
11.4.1 Anticoagulant Industry Trends
11.4.2 Anticoagulant Market Drivers
11.4.3 Anticoagulant Market Challenges
11.4.4 Anticoagulant Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anticoagulant Distributors
12.3 Anticoagulant Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
